High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity

Autor: Mari Bogaard, Kristina Totland Carm, Anne Cathrine Bakken, Marthe Løvf, Ulrika Axcrona, Karol Axcrona, Rolf Inge Skotheim, Susanne Gundersen Kidd, Linn Guro Olsen, Ragnhild A. Lothe

Publikováno v: Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 6, Pp 634-641 (2021)

Highlights • The lncRNA SCHLAP1 predicts poor prognosis in multifocal primary prostate cancer • Expression of SCHLAP1 is heterogeneous within and between different malignant foci • Multiple samples per patient is crucial, otherwise high SCHLAP1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b768b27a7196d73caecc39036fb558
https://doi.org/10.1016/j.neo.2021.05.012